Conditional deletion of Ccm2 causes hemorrhage in the adult brain: A mouse model of human cerebral cavernous malformations

Human Molecular Genetics

Volumn 20, Issue 16, 2011, Pages 3198-3206

  Cunningham, Kirk ^a   Uchida, Yutaka ^b   O'donnell, Erin ^b   Claudio, Estefania ^a   Li, Wenling ^b   Soneji, Kosha ^b   Wang, Hongshan ^a   Mukouyama, Yoh suke ^b   Siebenlist, Ulrich ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; CEREBRAL CAVERNOUS MALFORMATION 2 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DYSFUNCTION; BRAIN HEMORRHAGE; CAVERNOUS HEMANGIOMA; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE DELETION; HUMAN; LOSS OF FUNCTION MUTATION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REPRODUCIBILITY;

AGING; ANIMALS; BLOOD VESSELS; BRAIN; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; GENE DELETION; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HEMORRHAGE; HUMANS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICROFILAMENT PROTEINS; NEOVASCULARIZATION, PATHOLOGIC;

ANIMALIA; MUS;

EID: 79960823825     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr225     Document Type: Article

References (38)

1. Riant, F., Bergametti, F., Ayrignac, X., Boulday, G. and Tournier-Lasserve, E. (2010) Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS. J., 277, 1070-1075.
2. Chan, A.C., Li, D.Y., Berg, M.J. and Whitehead, K.J. (2010) Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype. FEBS. J., 277, 1076-1083.
3. Gault, J., Shenkar, R., Recksiek, P. and Awad, I.A. (2005) Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke, 36, 872-874.
4. Gault, J., Awad, I.A., Recksiek, P., Shenkar, R., Breeze, R., Handler, M. and Kleinschmidt-DeMasters, B.K. (2009) Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery, 65, 138-144.
5. Akers, A.L., Johnson, E., Steinberg, G.K., Zabramski, J.M. and Marchuk, D.A. (2009) Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum. Mol. Genet., 18, 919-930.
6. Pagenstecher, A., Stahl, S., Sure, U. and Felbor, U. (2009) A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum. Mol. Genet., 18, 911-918.
7. Whitehead, K.J., Plummer, N.W., Adams, J.A., Marchuk, D.A. and Li, D.Y. (2004) Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development, 131, 1437-1448.
8. Boulday, G., Blécon, A., Petit, N., Chareyre, F., Garcia, L.A., Niwa-Kawakita, M., Giovannini, M. and Tournier-Lasserve, E. (2009) Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations. Dis. Model. Mech., 2, 168-177.
9. Whitehead, K.J., Chan, A.C., Navankasattusas, S., Koh, W., London, N.R., Ling, J., Mayo, A.H., Drakos, S.G., Jones, C.A., Zhu, W. et al. (2009) The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat. Med., 15, 177-184.
10. Kleaveland, B., Zheng, X., Liu, J.J., Blum, Y., Tung, J.J., Zou, Z., Sweeney, S.M., Chen, M., Guo, L., Lu, M.M. et al. (2009) Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat. Med., 15, 169-176.
11. He, Y., Zhang, H., Yu, L., Gunel, M., Boggon, T.J., Chen, H. and Min, W. (2010) Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development. Sci. Signal., 3, ra26.
12. Denier, C., Goutagny, S., Labauge, P., Krivosic, V., Arnoult, M., Cousin, A., Benabid, A.L., Comoy, J., Frerebeau, P., Gilbert, B. et al. (2004) Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am. J. Hum. Genet., 74, 326-337.
13. Plummer, N.W., Squire, T.L., Srinivasan, S., Huang, E., Zawistowski, J.S., Matsunami, H., Hale, L.P. and Marchuk, D.A. (2006) Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations. Mamm. Genome., 17, 119-128.
14. Louvi, A., Chen, L., Two, A.M., Zhang, H., Min, W. and Gunel, M. (2011) Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. Proc. Natl Acad. Sci. USA., 108, 3737-3742.
15. Clatterbuck, R.E., Eberhart, C.G., Crain, B.J. and Rigamonti, D. (2001) Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J. Neurol. Neurosurg. Psychiatry, 71, 188-192.
16. Faurobert, E. and Albiges-Rizo, C. (2010) Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction. FEBS. J., 277, 1084-1096.
17. Plummer, N.W., Gallione, C.J., Srinivasan, S., Zawistowski, J.S., Louis, D.N. and Marchuk, D.A. (2004) Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. Am. J. Pathol., 165, 1509-1518.
18. Uhlik, M.T., Abell, A.N., Johnson, N.L., Sun, W., Cuevas, B.D., Lobel-Rice, K.E., Horne, E.A., Dell'Acqua, M.L. and Johnson, G.L. (2003) Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat. Cell. Biol., 5, 1104-1110.
19. Ellinger-Ziegelbauer, H., Brown, K., Kelly, K. and Siebenlist, U. (1997) Direct activation of the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by an inducible mitogen-activated protein Kinase/ERK kinase kinase 3 (MEKK) derivative. J. Biol. Chem., 272, 2668-2674.
20. Ellinger-Ziegelbauer, H., Kelly, K. and Siebenlist, U. (1999) Cell cycle arrest and reversion of Ras-induced transformation by a conditionally activated form of mitogen-activated protein kinase kinase kinase 3. Mol. Cell. Biol., 19, 3857-3868.
21. Liquori, C.L., Berg, M.J., Siegel, A.M., Huang, E., Zawistowski, J.S., Stoffer, T., Verlaan, D., Balogun, F., Hughes, L., Leedom, T.P. et al. (2003) Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am. J. Hum. Genet., 73, 1459-1464.
22. Kisanuki, Y.Y., Hammer, R.E., Miyazaki, J., Williams, S.C., Richardson, J.A. and Yanagisawa, M. (2001) Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol., 230, 230-242.
23. Strilić, B., Kucera, T., Eglinger, J., Hughes, M.R., McNagny, K.M., Tsukita, S., Dejana, E., Ferrara, N. and Lammert, E. (2009) The molecular basis of vascular lumen formation in the developing mouse aorta. Dev. Cell., 17, 505-515.
24. Schneider, A., Zhang, Y., Guan, Y., Davis, L.S. and Breyer, M.D. (2003) Differential, inducible gene targeting in renal epithelia, vascular endothelium, and viscera of Mx1Cre mice. Am. J. Physiol. Renal. Physiol., 284, F411-F417.
25. Hayashi, M., Kim, S.W., Imanaka-Yoshida, K., Yoshida, T., Abel, E.D., Eliceiri, B., Yang, Y., Ulevitch, R.J. and Lee, J.D. (2004) Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J. Clin. Invest., 113, 1138-1148.
26. Labauge, P., Denier, C., Bergametti, F. and Tournier-Lasserve, E. (2007) Genetics of cavernous angiomas. Lancet. Neurol., 6, 237-244.
27. Lawson, N.D., Scheer, N., Pham, V.N., Kim, C.H., Chitnis, A.B., Campos-Ortega, J.A. and Weinstein, B.M. (2001) Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development, 128, 3675-3683.
28. Lawson, N.D., Vogel, A.M. and Weinstein, B.M. (2002) Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev. Cell., 3, 127-136.
29. Mukouyama, Y.S., Gerber, H.P., Ferrara, N., Gu, C. and Anderson, D.J. (2005) Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback. Development, 132, 941-952.
30. Grego-Bessa, J., Luna-Zurita, L., del Monte, G., Bolós, V., Melgar, P., Arandilla, A., Garratt, A.N., Zang, H., Mukouyama, Y.S., Chen, H. et al. (2007) Notch signaling is essential for ventricular chamber development. Dev. Cell., 12, 415-429.
31. Wüstehube, J., Bartol, A., Liebler, S.S., Brütsch, R., Zhu, Y., Felbor U., Sure, U., Augustin, H.G. and Fischer, A. (2010) Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc. Natl Acad. Sci. USA., 107, 12640-12645.
32. Lim, M., Cheshier, S. and Steinberg, G.K. (2006) New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya. Curr. Neurovasc. Res., 3, 237-245.
33. Beck, H. and Plate, K.H. (2009) Angiogenesis after cerebral ischemia. Acta. Neuropathol., 117, 481-496.
34. Brütsch, R., Liebler, S.S., Wüstehube, J., Bartol, A., Herberich, S.E., Adam, M.G., Telzerow, A., Augustin, H.G. and Fischer, A. (2010) Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis. Circ. Res., 107, 592-601.
35. Voss, K., Stahl, S., Schleider, E., Ullrich, S., Nickel, J., Mueller, T.D. and Felbor, U. (2007) Evidence for anti-angiogenic and pro-survival functions of the cerebral cavernous malformation protein 3. Neurogenetics, 12, 83-86.
36. Zhu, Y., Wu, Q., Xu, J.F., Miller, D., Sandalcioglu, I.E., Zhang, J.M. and Sure, U. (2010) Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations. Neurosurg. Focus, 29, E1.
37. McDonald, D.A., Shenkar, R., Shi, C., Stockton, R.A., Akers, A.L., Kucherlapati, M.H., Kucherlapati, R., Brainer, J., Ginsberg, M.H., Awad, I.A. et al. (2011) A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum. Mol. Gen., 20, 211-222.
38. Kuhn, R., Schwenk, F., Aguet, M. and Rajewsky, K. (1995) Inducible gene targeting in mice. Science, 269, 1427-1429.